Antisocial Personality Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
63
|
6
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2015 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2015 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
985
|
59
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Atrial Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
939
|
584
|
0.020 |
None |
0.500 |
2 |
|
2016 |
2017 |
Atypical Ductal Breast Hyperplasia
|
disease |
Neoplasms
|
Neoplastic Process
|
80
|
17
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Autosomal dominant hypocalcemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
29
|
9
|
0.030 |
None |
1.000 |
3 |
|
2016 |
2020 |
Benign Neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
371
|
7
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Bipolar I disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
83
|
46
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Bipolar II disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
21
|
12
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Blood spots
|
disease |
|
Disease or Syndrome
|
117
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Blood urea nitrogen measurement
|
phenotype |
|
Laboratory Procedure
|
90
|
174
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
2 |
1
|
2017 |
2019 |
Brain atrophy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
182
|
46
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.070 |
None |
0.857 |
7 |
2
|
2005 |
2018 |
Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.080 |
None |
0.875 |
8 |
1
|
2001 |
2018 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Carcinoma of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
456
|
65
|
0.030 |
None |
0.667 |
3 |
1
|
2003 |
2016 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.120 |
None |
0.667 |
3 |
3
|
2012 |
2019 |
Cerebral atrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
454
|
44
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |